Insider Transactions in Q1 2022 at Centene Corp (CNC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
457
+1.65%
|
$37,474
$82.02 P/Share
|
|
Mar 31
2022
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
472
+0.51%
|
$38,704
$82.02 P/Share
|
|
Mar 31
2022
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
381
+20.46%
|
$31,242
$82.02 P/Share
|
|
Mar 31
2022
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+0.13%
|
$34,932
$82.02 P/Share
|
|
Mar 31
2022
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
381
+20.46%
|
$31,242
$82.02 P/Share
|
|
Mar 31
2022
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
381
+0.1%
|
$31,242
$82.02 P/Share
|
|
Mar 31
2022
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
381
+20.46%
|
$31,242
$82.02 P/Share
|
|
Mar 31
2022
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
441
+22.25%
|
$36,162
$82.02 P/Share
|
|
Mar 29
2022
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,453
+21.45%
|
$7,603,505
$85.24 P/Share
|
|
Mar 24
2022
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-0.84%
|
$244,114
$82.46 P/Share
|
|
Mar 24
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,690
-2.34%
|
$302,580
$82.71 P/Share
|
|
Mar 24
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-1.86%
|
$244,114
$82.46 P/Share
|
|
Mar 24
2022
|
Shannon Bagley EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,044
-2.18%
|
$249,608
$82.46 P/Share
|
|
Mar 24
2022
|
Brent D Layton President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,977
-0.55%
|
$244,114
$82.46 P/Share
|
|
Mar 15
2022
|
Colin A Toney EVP, Mergers & Acquisitions |
SELL
Payment of exercise price or tax liability
|
Direct |
947
-1.72%
|
$79,548
$84.33 P/Share
|
|
Mar 15
2022
|
Katie Casso Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
530
-1.44%
|
$44,520
$84.33 P/Share
|
|
Mar 11
2022
|
Katie Casso Corporate Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,737
+11.43%
|
$397,908
$84.44 P/Share
|
|
Mar 02
2022
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,227
-0.86%
|
$184,841
$83.15 P/Share
|
|
Feb 28
2022
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-1.08%
|
$215,800
$83.52 P/Share
|
|
Feb 07
2022
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Wayne S De Veydt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Theodore R. Samuels Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Feb 07
2022
|
Kenneth A Burdick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+0.28%
|
-
|
|
Feb 07
2022
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,100
+50.0%
|
-
|
|
Jan 23
2022
|
Andrew Lynn Asher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-0.89%
|
$178,948
$77.14 P/Share
|
|
Jan 21
2022
|
Kenneth A Burdick Director |
SELL
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
179,000
-67.42%
|
$13,425,000
$75.0 P/Share
|
|
Jan 20
2022
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,774
-1.7%
|
$221,920
$80.0 P/Share
|
|
Jan 11
2022
|
David P Thomas CEO, Markets and Medicaid |
SELL
Open market or private sale
|
Direct |
4,000
-4.64%
|
$308,000
$77.61 P/Share
|